DaVita Total Liabilities 2010-2024 | DVA

DaVita total liabilities from 2010 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
  • DaVita total liabilities for the quarter ending March 31, 2024 were $16.298B, a 3.76% increase year-over-year.
  • DaVita total liabilities for 2023 were $15.65B, a 2.51% decline from 2022.
  • DaVita total liabilities for 2022 were $16.052B, a 0.82% decline from 2021.
  • DaVita total liabilities for 2021 were $16.185B, a 4.95% increase from 2020.
DaVita Annual Total Liabilities
(Millions of US $)
2023 $15,650
2022 $16,052
2021 $16,185
2020 $15,422
2019 $14,992
2018 $15,202
2017 $14,088
2016 $13,906
2015 $13,431
2014 $12,257
2013 $12,493
2012 $12,098
2011 $6,636
2010 $6,077
2009 $5,364
DaVita Quarterly Total Liabilities
(Millions of US $)
2024-03-31 $16,298
2023-12-31 $15,650
2023-09-30 $15,549
2023-06-30 $15,753
2023-03-31 $15,708
2022-12-31 $16,052
2022-09-30 $16,260
2022-06-30 $16,325
2022-03-31 $16,069
2021-12-31 $16,185
2021-09-30 $16,306
2021-06-30 $16,347
2021-03-31 $16,214
2020-12-31 $15,422
2020-09-30 $15,293
2020-06-30 $16,971
2020-03-31 $15,463
2019-12-31 $14,992
2019-09-30 $14,939
2019-06-30 $15,688
2019-03-31 $18,519
2018-12-31 $15,202
2018-09-30 $15,329
2018-06-30 $14,951
2018-03-31 $14,160
2017-12-31 $14,088
2017-09-30 $14,044
2017-06-30 $14,070
2017-03-31 $14,048
2016-12-31 $13,906
2016-09-30 $13,806
2016-06-30 $13,733
2016-03-31 $13,592
2015-12-31 $13,431
2015-09-30 $13,703
2015-06-30 $13,600
2015-03-31 $13,196
2014-12-31 $12,257
2014-09-30 $12,950
2014-06-30 $12,969
2014-03-31 $12,561
2013-12-31 $12,493
2013-09-30 $12,390
2013-06-30 $12,173
2013-03-31 $12,457
2012-12-31 $12,098
2012-09-30 $8,154
2012-06-30 $6,747
2012-03-31 $6,755
2011-12-31 $6,636
2011-09-30 $6,624
2011-06-30 $6,247
2011-03-31 $6,186
2010-12-31 $6,077
2010-09-30 $5,251
2010-06-30 $5,221
2010-03-31 $5,373
2009-12-31 $5,364
2009-09-30 $5,399
2009-06-30 $5,385
2009-03-31 $5,311
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $12.399B $12.140B
DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals across the U.S. Its services include outpatient dialysis services, hospital inpatient dialysis services and ancillary services such as ESRD laboratory services and disease management services. DaVita's Dialysis and related lab services business segment provides inpatient as well as outpatient dialysis services, routine laboratory testing for ESRD patients and management services to outpatient dialysis centers. The company's other ancillary services and strategic initiatives segment includes its international dialysis services, pharmacy services, infusion therapy services, disease management services, vascular access services, ESRD clinical research programs and physician services.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $16.911B 0.00
Quest Diagnostics (DGX) United States $15.437B 15.95
Elanco Animal Health (ELAN) United States $8.920B 23.14
Encompass Health (EHC) United States $8.544B 21.87
Chemed (CHE) United States $8.213B 25.46
Option Care Health (OPCH) United States $4.898B 18.54
RadNet (RDNT) United States $4.340B 90.37
Amedisys (AMED) United States $2.999B 21.24
Astrana Health (ASTH) United States $2.312B 31.26
LifeStance Health (LFST) United States $2.022B 0.00
Addus HomeCare (ADUS) United States $1.939B 27.74
U.S Physical Therapy (USPH) United States $1.388B 37.15
Pennant (PNTG) United States $0.677B 35.75
Aveanna Healthcare Holdings (AVAH) United States $0.492B 0.00
Atai Life Sciences (ATAI) Germany $0.224B 0.00
Daxor (DXR) United States $0.043B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.024B 0.00
ATI Physical Therapy (ATIP) United States $0.022B 0.00
Novo Integrated Sciences (NVOS) United States $0.016B 0.00
Psychemedics (PMD) United States $0.014B 0.00
Ontrak (OTRK) United States $0.011B 0.00
IMAC Holdings (BACK) United States $0.003B 0.00